259 related articles for article (PubMed ID: 11454507)
41. Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours.
Luciani P; Buci L; Conforti B; Tonacchera M; Agretti P; Elisei R; Vivaldi A; Cioppi F; Biliotti G; Manca G; Vitti P; Serio M; Peri A
Eur J Endocrinol; 2003 May; 148(5):579-86. PubMed ID: 12720543
[TBL] [Abstract][Full Text] [Related]
42. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas.
Gérard AC; Daumerie C; Mestdagh C; Gohy S; De Burbure C; Costagliola S; Miot F; Nollevaux MC; Denef JF; Rahier J; Franc B; De Vijlder JJ; Colin IM; Many MC
J Clin Endocrinol Metab; 2003 Oct; 88(10):4977-83. PubMed ID: 14557483
[TBL] [Abstract][Full Text] [Related]
43. BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.
Durante C; Puxeddu E; Ferretti E; Morisi R; Moretti S; Bruno R; Barbi F; Avenia N; Scipioni A; Verrienti A; Tosi E; Cavaliere A; Gulino A; Filetti S; Russo D
J Clin Endocrinol Metab; 2007 Jul; 92(7):2840-3. PubMed ID: 17488796
[TBL] [Abstract][Full Text] [Related]
44. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
Spitzweg C; Joba W; Morris JC; Heufelder AE
Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
[TBL] [Abstract][Full Text] [Related]
45. Expression of human beta-defensins-1-4 in thyroid cancer cells and new insight on biologic activity of hBD-2 in vitro.
Zhuravel OV; Gerashchenko OL; Khetsuriani MR; Soldatkina MA; Pogrebnoy PV
Exp Oncol; 2014 Sep; 36(3):174-8. PubMed ID: 25265350
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
47. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
48. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles.
Pauws E; Veenboer GJ; Smit JW; de Vijlder JJ; Morreau H; Ris-Stalpers C
FASEB J; 2004 Mar; 18(3):560-1. PubMed ID: 14715705
[TBL] [Abstract][Full Text] [Related]
49. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
[TBL] [Abstract][Full Text] [Related]
50. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
51. [Estimation of sodium/iodide symporter gene expression (NIS) in thyroid cancer by RT-PCR technique (preliminary study)].
Tosiek M; Pomorski L; Balcerczak E; Mirowski M; Czyz W
Endokrynol Pol; 2005; 56(1):25-9. PubMed ID: 16335670
[TBL] [Abstract][Full Text] [Related]
52. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas.
Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF
Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333
[TBL] [Abstract][Full Text] [Related]
54. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
[TBL] [Abstract][Full Text] [Related]
55. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
Biscolla RP; Cerutti JM; Maciel RM
J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
[TBL] [Abstract][Full Text] [Related]
56. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
57. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
Bastos AU; Oler G; Nozima BH; Moysés RA; Cerutti JM
Eur J Endocrinol; 2015 Oct; 173(4):525-40. PubMed ID: 26338373
[TBL] [Abstract][Full Text] [Related]
58. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
59. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
60. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
